- Home
- BMA vs PBH Comparison
BMA vs PBH Comparison
Compare BMA & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMA
- PBH
- Stock Information
- Founded
- BMA 1966
- PBH 1996
- Country
- BMA Argentina
- PBH United States
- Employees
- BMA N/A
- PBH N/A
- Industry
- BMA Commercial Banks
- PBH Biotechnology: Pharmaceutical Preparations
- Sector
- BMA Finance
- PBH Health Care
- Exchange
- BMA Nasdaq
- PBH Nasdaq
- Market Cap
- BMA 4.6B
- PBH 3.8B
- IPO Year
- BMA 2006
- PBH 2005
- Fundamental
- Price
- BMA $71.12
- PBH $64.82
- Analyst Decision
- BMA Hold
- PBH Buy
- Analyst Count
- BMA 3
- PBH 5
- Target Price
- BMA $54.50
- PBH $94.00
- AVG Volume (30 Days)
- BMA 362.7K
- PBH 427.0K
- Earning Date
- BMA 08-21-2025
- PBH 08-07-2025
- Dividend Yield
- BMA 0.51%
- PBH N/A
- EPS Growth
- BMA N/A
- PBH 4.18
- EPS
- BMA N/A
- PBH 4.26
- Revenue
- BMA $2,661,558,665.00
- PBH $1,120,150,000.00
- Revenue This Year
- BMA N/A
- PBH $2.04
- Revenue Next Year
- BMA $12.14
- PBH $2.07
- P/E Ratio
- BMA N/A
- PBH $15.93
- Revenue Growth
- BMA N/A
- PBH 0.63
- 52 Week Low
- BMA $47.01
- PBH $64.94
- 52 Week High
- BMA $118.42
- PBH $90.04
- Technical
- Relative Strength Index (RSI)
- BMA 55.68
- PBH 19.75
- Support Level
- BMA $67.15
- PBH $72.53
- Resistance Level
- BMA $76.04
- PBH $75.31
- Average True Range (ATR)
- BMA 2.78
- PBH 1.75
- MACD
- BMA 0.97
- PBH -0.57
- Stochastic Oscillator
- BMA 80.78
- PBH 2.11
About BMA Banco Macro S.A. ADR (representing Ten Class B)
Banco Macro SA is a financial institution and it provides standard banking products and services designed to suit individual needs. It has two categories of customers, retail customers, which include individuals and entrepreneurs, and corporate customers, which include small, medium, and large companies and corporations. In addition, it provides services to four provincial governments. It generates the majority of its revenue from Argentina.
About PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.